Cipla’s arm completes sale of entire shareholding in Wellthy

07 Mar 2024 Evaluate

Cipla’s wholly owned subsidiary -- Goldencross Pharma (Goldencross) has completed the sale of its entire shareholding in Wellthy Therapeutics (Wellthy) in terms of the definitive agreement executed on March 06, 2024. The consideration received from such sale is Rs 59.71 lakh for the sale of 5,32,121 Compulsorily Convertible Preference Shares (CCPS) and 10 equity shares held in Wellthy.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. 

Cipla Share Price

1476.45 4.00 (0.27%)
23-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1814.50
Dr. Reddys Lab 1340.80
Cipla 1476.45
Lupin 2160.20
Zydus Lifesciences 972.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.